Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CD93 |
| Upstream (Parents) |
|---|
| (<<) C1orf54 → CD93 |
| (<<) ELTD1 → CD93 |
| (<<) SNAI2 → CD93 |
| (<<) GUCY1B3 → CD93 |
| Downstream (Children) |
|---|
| CD93 → RASGRP3 (>>) |
| CD93 → C1orf54 (>>) |
| CD93 → PCDH17 (>>) |
| CD93 → SOX17 (>>) |
| CD93 → COL5A3 (>>) |
| CD93 → LAMA4 (>>) |
| CD93 → CDK6 (>>) |
| CD93 → ZFPM2 (>>) |
| CD93 → ELTD1 (>>) |
| CD93 → OLFML1 (>>) |
| CD93 → SOX18 (>>) |
| CD93 → CALCRL (>>) |
| CD93 → PECAM1 (>>) |
| CD93 → MEF2C (>>) |
| CD93 → SPATS2L (>>) |
| CD93 → THBD (>>) |
| CD93 → GPR116 (>>) |
